Glucosamine supplements may speed memory loss from Alzheimer’s, new research shows
In The Conversation, Dr. Ramon Sun discusses his study reporting an increased mortality risk among Alzheimer's patients using Glucosamine.
Posted in
Neurological Diseases News
Study links joint pain supplement to accelerating dementia
An analysis by MBI researchers shows that glucosamine use is associated with a 25% increase in progression from mild cognitive impairment to dementia.
MBI Researcher Highlight: Dr. Kimberly Alonge
Dr. Kimberly Alonge's research explores the role of the brain’s extracellular matrices in neuro disorders as well as in aging, obesity and diabetes.
Researchers develop AI tool to improve dementia diagnosis
Research team seeks to improve clinicians’ ability to distinguish between diseases involving dementia.
Florida officials unveil $4.2M in Alzheimer’s research grants at the MBI
The Ed and Ethel Moore Alzheimer’s Disease Research Program supports researchers advancing discovery, prevention and treatment in dementia research.
MBI community mourns renowned neuroscientist Dr. Brent Reynolds
Dr. Brent Reynolds, whose discovery of neural stem cells in adult mammalian brains opened a whole new field of neuroscience research, died unexpectedly April 11 after a stroke.
MBI researcher honored internationally for mRNA cancer vaccine work
Dr. Elias Sayour was one of three scientists worldwide honored at the 2026 BioInnovation Institute & Science Prize for Innovation ceremony.
Dr. John Ligon named Rising Star in Clinical Science
MBI researcher wins 2026 UF College of Medicine Rising Star Researcher in Clinical Science Award.
MBI Spatial Transcriptomics Pilot Award supports 11 research projects
MBI awards provide seed funding to bolster emerging research in neuroscience and neuromedicine across the University of Florida.
Dr. Lee Sweeney wins Basic Science Award
MBI researcher received the 2026 UF College of Medicine Outstanding Research Scientist in Basic Science Award.
